WEIWEN ZHENG

Allopathic & Osteopathic Physicians|Family Medicine SAN FRANCISCO, CA NPI 1023059201

General Payments — all program years on this page

$5,636.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 169
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,286.26 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,286.2619

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $187.472
2019 $462.0918
2020 $642.1936
2021 $564.3529
2022 $1,379.0042
2023 $1,115.1423
2024 $1,286.2619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077939828 Janssen Pharmaceuticals, Inc $128.87 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077939856 Janssen Pharmaceuticals, Inc $149.98 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077939874 Janssen Pharmaceuticals, Inc $25.33 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077939934 Janssen Pharmaceuticals, Inc $33.09 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077940034 Janssen Pharmaceuticals, Inc $23.02 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077940072 Janssen Pharmaceuticals, Inc $18.46 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077940088 Janssen Pharmaceuticals, Inc $27.68 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077940176 Janssen Pharmaceuticals, Inc $30.00 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112788040 ViiV Healthcare Company $125.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116223871 Amgen Inc. $28.20 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116515189 GlaxoSmithKline, LLC. $79.38 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116666931 GlaxoSmithKline, LLC. $29.22 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117725739 Amgen Inc. $145.62 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135512179 Lilly USA, LLC $98.34 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137520533 Ferring Pharmaceuticals Inc. $19.99 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138838370 Edwards Lifesciences Corporation $88.17 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149641944 Agios Pharmaceuticals, Inc. $38.74 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151142933 Phathom Pharmaceuticals, Inc. $70.31 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153343763 Dexcom, Inc. $126.86 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.